SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco QQQ Trust Series 1 - Units of beneficial interest

The Invesco QQQ Trust (QQQ) is experiencing high volatility as markets react to conflicting headlines regarding a potential ceasefire between the U.S. and Iran, with traders debating whether the latest extension of the diplomatic deadline is a genuine breakthrough or a strategic stall. The community remains deeply divided, with many expressing skepticism over the veracity of news sources while others remain focused on the potential for massive, policy-driven market swings.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending as investors and the community closely monitor escalated geopolitical rhetoric and the potential for a widened conflict in the Middle East, with intense debate centering on the stock's exposure to administration policy shifts and volatile energy markets. The discussion is heavily influenced by social media reactions to current events, ranging from extreme bullish optimism regarding defense and oil policy to sharp skepticism concerning the economic impact of ongoing international instability.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

SPY is experiencing high volatility as markets react to conflicting headlines regarding a potential 45-day ceasefire between the U.S. and Iran, a recurring theme that investors are increasingly skeptical of. The community remains deeply divided, with many traders questioning the integrity of these reports while others are positioning for a relief rally based on potential de-escalation.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is currently trending due to intensifying speculation regarding a potential buyout or major partnership, fueled by activist pressure from Shah Capital to unlock shareholder value. While the company's core technology remains a focal point of community discussion, investor frustration is high due to ongoing volatility and silence from leadership regarding the status of key assets like the CIC vaccine.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares (SOXS) is seeing intense trading activity as investors weigh the semiconductor sector's high valuation against geopolitical tensions and concerns over a potential AI bubble. Community discussion is split between those aggressively scalping the volatility for quick gains and bears positioning for a major market correction, with many traders closely monitoring semiconductor earnings and macroeconomic data as potential catalysts for a breakdown.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is currently trending due to its innovative WVE-007 obesity program, which aims to provide a differentiated 'muscle-sparing' alternative to traditional GLP-1 therapies through RNA interference. Investors and the biotech community are actively discussing the company's potential as a prime acquisition target as major pharmaceutical firms scramble to secure next-generation obesity assets before looming patent cliffs.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

iShares Semiconductor ETF (SOXX) is currently a focal point for intense debate, as investors weigh sustained demand for AI-driven infrastructure against technical indicators suggesting the sector may be overextended. The community remains deeply divided, with bulls pointing to robust long-term growth and consistent dip-buying as signs of a 'buy the dip' market, while skeptics warn of a speculative bubble, citing concerns over high valuations, trade policy impacts, and potential mean reversion.

Direxion Shares ETF Trust - Direxion Small Cap Bear 3X ETF

Direxion Daily Small Cap Bear 3X Shares

The community is actively trading TZA to hedge against small-cap volatility and shifting economic expectations, with many users debating the sustainability of recent rallies and potential market downturns. Discussions heavily emphasize using inverse ETFs like TZA as a strategic tool to capitalize on market dips, while others express caution regarding the long-term decay risks inherent in holding leveraged products.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - VR PRF PERPETUAL USD 100 - Ser A

Strategy Inc Variable Rate Series A Perpetual Stretch Preferred

Strategy Inc. (STRC) is trending as investors capitalize on its perpetual preferred series, which offers a double-digit yield and serves as a liquidity engine for aggressive Bitcoin accumulation. While the community is actively debating the sustainability of this 'digital credit' flywheel and its potential impact on Bitcoin price action, many are treating the instrument as a high-yield vehicle to park capital while the company scales its treasury holdings.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending amid intense market volatility driven by escalating geopolitical tensions in the Middle East, specifically the blockage of the Strait of Hormuz and reports of strikes on critical energy infrastructure. Investors are closely monitoring a looming policy deadline and conflicting headlines regarding potential ceasefires, fueling a debate among the community between positioning for a structural oil supply crisis or betting on a rapid de-escalation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) has been given a consensus rating of "Moderate Buy" by the nine ratings firms that are covering the company, Marketbeat reports. One investment...

Biomea Fusion Details Icovamenib Diabetes Milestones, Teases BMF-650 Obesity Readouts

Executives from Biomea Fusion (NASDAQ:BMEA) discussed the company's lead diabetes program, icovamenib, and outlined near-term clinical milestones during a recent company event hosted by an operator...

Biomea Fusion Teases Q2 Phase 1 Data for Oral GLP-1 BMF-650, Advances Icovamenib in Diabetes

Biomea Fusion (NASDAQ:BMEA) outlined several near-term clinical milestones and development priorities during a JPMorgan conference call, with executives emphasizing upcoming Phase I data for its oral GLP-1 receptor agonist candidate BMF-650 and continued advancement of icovamenib in diabetes.

BMF-6...

Biomea Fusion (NASDAQ:BMEA) Upgraded by Wall Street Zen to Hold Rating

Wall Street Zen upgraded shares of Biomea Fusion from a "sell" rating to a "hold" rating in a report on Saturday...

Biomea Fusion (NASDAQ:BMEA) Price Target Raised to $7.00 at Citigroup

Citigroup increased their price objective on Biomea Fusion from $6.00 to $7.00 and gave the stock a "buy" rating in a report on Friday...

HC Wainwright Comments on Biomea Fusion Q1 Earnings

Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) - Equities researchers at HC Wainwright issued their Q1 2026 earnings estimates for Biomea Fusion in a research report issued to clients and investors...

Biomea Fusion's (BMEA) Buy Rating Reaffirmed at D. Boral Capital

D. Boral Capital restated a "buy" rating and set a $12.00 target price on shares of Biomea Fusion in a research report on Wednesday...

Biomea Fusion (NASDAQ:BMEA) Issues Quarterly Earnings Results

Biomea Fusion (NASDAQ:BMEA - Get Free Report) released its quarterly earnings data on Tuesday. The company reported $0.27 EPS for the quarter, beating analysts' consensus estimates of ($0.25) by...

Biomea Fusion (BMEA) Expected to Announce Quarterly Earnings on Monday

Biomea Fusion (NASDAQ:BMEA) will be releasing its Q4 2025 earnings before the market opens on Monday, March 30. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-30-biomea-fusion-inc-stock...

Heights Capital Management Inc. Reduces Stock Holdings in Biomea Fusion, Inc. $BMEA

Heights Capital Management Inc. reduced its position in shares of Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) by 62.6% in the 3rd quarter, according to the company in its most recent disclosure...

This account has been verified as an official BMEA representative.

Verified Account

Biomea Fusion IR

Biomea Fusion, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic disorders, such as diabetes. It offers its lead product candidate, BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. The company was founded by Thomas Butler and Ramses Erdtmann in August 2017 and is headquartered in San Carlos, CA.

Biomea Fusion Inc

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Current Price	$1.54
Prev Close	$1.49
Open	$1.47
Dividend Yield	0.00%
50-Day Moving Average	$1.30
Beta	1.55
Avg. Volume	1.33M
PE Ratio	-1.01

52-Week High	$3.08
52-Week Low	$0.8719
Market Capitalization	$111.34M
EPS (Annual)	-$1.18
Price to Book	3.77
Revenue Per Employee	$0.00

BMEA
Biomea Fusion Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BMEA News

BMEABiomea Fusion Inc